Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03038308
Recruitment Status : Recruiting
First Posted : January 31, 2017
Last Update Posted : September 2, 2019
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Gabrielle Page-Wilson, Columbia University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : July 2020